Abstract:Lung cancer (LC) is one of the most common cancer worldwide. Tumor-associated macrophages (TAMs) are important component of the tumor microenvironment (TME) and are closely related to the stages of tumor occurrence, development, and metastasis. Macrophages are plastic and can differentiate into different phenotypes and functions under the influence of different signaling pathways in TME. The classically activated (M1-like) and alternatively activated (M2-like) represent the two polarization states of macrophages. M1 macrophages exhibit anti-tumor functions, while M2 macrophages are considered to support tumor cell survival and metastasis. Macrophage polarization involves complex signaling pathways, and blocking or regulating these signaling pathways to enhance macrophages' anti-tumor effects has become a research hotspot in recent years. At the same time, there have been new discoveries regarding the modulation of TAMs towards an anti-tumor phenotype by synthetic and natural drug components. Nanotechnology can better achieve combination therapy and targeted delivery of drugs, maximizing the efficacy of the drugs while minimizing side effects. Up to now, nanomedicines targeting the delivery of various active substances for reprogramming TAMs have made significant progress. In this review, we primarily provided a comprehensive overview of the signaling crosstalk between TAMs and various cells in the LC microenvironment. Additionally, the latest advancements in novel drugs and nano-based drug delivery systems (NDDSs) that target macrophages were also reviewed. Finally, we discussed the prospects of macrophages as therapeutic targets and the barriers to clinical translation.

Cutting edges and therapeutic opportunities on tumor-associated macrophages in lung cancer

Research advances on signaling pathways regulating the polarization of tumor-associated macrophages in lung cancer microenvironment

Shedding light on macrophage immunotherapy in lung cancer

Tumor-associated macrophages: potential therapeutic strategies and future prospects in cancer

Macrophage polarization in the tumor microenvironment: Emerging roles and therapeutic potentials

A narrative review of tumor-associated macrophages in lung cancer: regulation of macrophage polarization and therapeutic implications

Tumor‐associated macrophages in lung cancer: Friendly or evil? (Review)

Targeting tumor-associated macrophages for cancer treatment

Roles of Tumor-Associated Macrophages in Tumor Environment and Strategies for Targeting Therapy

The role of tumor-associated macrophages in lung cancer: From mechanism to small molecule therapy

Tumor-associated Macrophages in Lung Carcinoma: from Mechanism to Therapy.

Tumor-Associated Macrophages: Recent Insights and Therapies

Targeting Tumor-Associated Macrophages in Cancer Immunotherapy

Tumor-associated macrophages: A promising target for a cancer immunotherapeutic strategy

Dynamic polarization of tumor-associated macrophages and their interaction with intratumoral T cells in an inflamed tumor microenvironment: from mechanistic insights to therapeutic opportunities

Targeting tumor-associated macrophages to synergize tumor immunotherapy

New insights into the role of macrophages in cancer immunotherapy

Crosstalk between Tumor-Associated Macrophages and MicroRNAs: A Key Role in Tumor Microenvironment

The hypoxia-driven crosstalk between tumor and tumor-associated macrophages: mechanisms and clinical treatment strategies

Research Progress on the Role of Tumor‑associated Macrophages in Tumor Development and Their Use As Molecular Targets (Review).

Targeting tumor‑associated macrophages: Critical players in tumor progression and therapeutic strategies (Review)